Idoxuridine
Nucleoside Analog Antiviral — DERMATOLOGICALS
Also known as: allergan, idoxene, idoxuridin, iododeoxyuridine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Idoxuridine is an ofm drug in the Nucleoside Analog Antiviral class catalogued in DrugCentral. It was first approved by the FDA in 1963. DrugCentral lists 2 molecular targets, including TK1 and UL23. Recorded indications include Herpes simplex keratitis.
- Approval status: ofm (first approved 1963 by the FDA).
- Drug class: Nucleoside Analog Antiviral.
- Molecular targets: TK1 and UL23 (2 listed in DrugCentral).
- Indications: Herpes simplex keratitis.
- ATC code: D06BB01 (Antivirals).
- Molecular formula: C9H11IN2O5; molecular weight 354.10 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Herpes simplex keratitis
Off-label uses (1)
- Vaccinia keratitis
Mechanism & targets
| Established pharmacologic class | Nucleoside Analog Antiviral |
|---|
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Thymidine kinase, cytosolic | TK1 | unknown | Ki 7.05 |
| Thymidine kinase | UL23 | unknown | IC50 5.82 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1963-06-11 | FDA | — | ALLERGAN |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
D06BB01 | DERMATOLOGICALS › ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE › CHEMOTHERAPEUTICS FOR TOPICAL USE › Antivirals |
J05AB02 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIVIRALS FOR SYSTEMIC USE › DIRECT ACTING ANTIVIRALS › Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
S01AD01 | SENSORY ORGANS › OPHTHALMOLOGICALS › ANTIINFECTIVES › Antivirals |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Idoxuridine is on its molecule page.
| Molecular formula | C9H11IN2O5 |
|---|---|
| Molecular weight | 354.10 g/mol |
| CAS number | 54-42-2 |
| InChIKey | XQFRJNBWHJMXHO-RRKCRQDMSA-N |
| PubChem CID | 5905 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Idoxuridine used for?
DrugCentral lists the following indications for Idoxuridine: Herpes simplex keratitis.
How does Idoxuridine work?
Its molecular targets in DrugCentral include TK1 and UL23.
When was Idoxuridine first approved?
Idoxuridine was first approved by the FDA in 1963.
What drug class does Idoxuridine belong to?
Idoxuridine is in the Nucleoside Analog Antiviral class.
What is the chemical formula of Idoxuridine?
Idoxuridine has the molecular formula C9H11IN2O5 and a molecular weight of 354.10 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1417 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL788 — compound record and bioactivity
- PubChem CID 5905 — chemical identifiers
- DrugBank DB00249 — drug record
- FDA UNII LGP81V5245 — substance identity
- DailyMed: FDA labels for Idoxuridine — current prescribing information (label search)
- UniProt P04183 (TK1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.